Ascend Advanced Therapies Partners with EW Healthcare Partners to Expand United States Capacity and Capabilities | PR Newswire [Video]

, /PRNewswire/ — Ascend Advanced Therapies (Ascend), a gene-to-GMP development partner, has partnered with EW Healthcare Partners to expand the footprint and capabilities of the company in the US and to continue investing further in infrastructure. Advanced BioScience Laboratories (ABL), a biotherapy, oncolytic and viral vector contract development, and manufacturing organization (CDMO) located in Rockville, MD, a portfolio company of EW Healthcare Partners, will become part of Ascend. EW will also make a significant capital investment in Ascend to support continued growth of the company.

“We founded Ascend with a vision to quilt together the best operators and technologies within the advanced manufacturing field. The complementary services at ABL and Ascend will further strengthen our service offering to customers,” said Fred Cohen, Chairman of Ascend and Founding investor at Monograph Capital offered. “We look forward to working with our new colleagues at the Rockville facility and our partners at EW.”

The addition of the ABL Rockville team and facility aligns more …